0 XP   0   0   0

INDOCO REMEDIES LTD.
Buy, Hold or Sell?

Should you buy, hold or sell INDOCO REMEDIES LTD.?

I guess you are interested in INDOCO REMEDIES LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse INDOCO REMEDIES LTD.

Let's start. I'm going to help you getting a better view of INDOCO REMEDIES LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is INDOCO REMEDIES LTD. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how INDOCO REMEDIES LTD. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value INDOCO REMEDIES LTD.. The closing price on 2023-01-27 was INR338.45 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
INDOCO REMEDIES LTD. Daily Candlestick Chart
INDOCO REMEDIES LTD. Daily Candlestick Chart
Summary









1. Valuation of INDOCO REMEDIES LTD.




Current price per share

INR338.45

2. Growth of INDOCO REMEDIES LTD.




Is INDOCO REMEDIES LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$111.2m$94.5m$16.6m15.0%

How much money is INDOCO REMEDIES LTD. making?

Current yearPrevious yearGrowGrow %
Making money$19m$11.4m$7.5m39.9%
Net Profit Margin10.0%7.5%--

How much money comes from the company's main activities?

3. Financial Health of INDOCO REMEDIES LTD.




Comparing to competitors in the industry




  Industry Rankings ()  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of INDOCO REMEDIES LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit INDOCO REMEDIES LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare INDOCO REMEDIES LTD. to the  industry mean.
  • A Net Profit Margin of 10.0% means that ₹0.10 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of INDOCO REMEDIES LTD.:

  • The MRQ is 10.0%. The company is making a huge profit. +2
  • The TTM is 10.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ10.0%TTM10.0%0.0%
TTM10.0%YOY7.5%+2.6%
TTM10.0%5Y4.7%+5.4%
5Y4.7%10Y5.1%-0.4%
1.1.2. Return on Assets

Shows how efficient INDOCO REMEDIES LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare INDOCO REMEDIES LTD. to the  industry mean.
  • 10.4% Return on Assets means that INDOCO REMEDIES LTD. generated ₹0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of INDOCO REMEDIES LTD.:

  • The MRQ is 10.4%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 10.4%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ10.4%TTM10.4%0.0%
TTM10.4%YOY7.1%+3.3%
TTM10.4%5Y4.5%+5.9%
5Y4.5%10Y4.8%-0.3%
1.1.3. Return on Equity

Shows how efficient INDOCO REMEDIES LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare INDOCO REMEDIES LTD. to the  industry mean.
  • 17.1% Return on Equity means INDOCO REMEDIES LTD. generated ₹0.17 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of INDOCO REMEDIES LTD.:

  • The MRQ is 17.1%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 17.1%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ17.1%TTM17.1%0.0%
TTM17.1%YOY12.1%+5.0%
TTM17.1%5Y7.7%+9.4%
5Y7.7%10Y8.4%-0.7%

1.2. Operating Efficiency of INDOCO REMEDIES LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient INDOCO REMEDIES LTD. is operating .

  • Measures how much profit INDOCO REMEDIES LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare INDOCO REMEDIES LTD. to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of INDOCO REMEDIES LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y2.4%-2.4%
5Y2.4%10Y3.5%-1.0%
1.2.2. Operating Ratio

Measures how efficient INDOCO REMEDIES LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.17 means that the operating costs are ₹1.17 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of INDOCO REMEDIES LTD.:

  • The MRQ is 1.173. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.173. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.173TTM1.1730.000
TTM1.173YOY1.183-0.010
TTM1.1735Y1.072+0.101
5Y1.07210Y0.957+0.115

1.3. Liquidity of INDOCO REMEDIES LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if INDOCO REMEDIES LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 1.82 means the company has ₹1.82 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of INDOCO REMEDIES LTD.:

  • The MRQ is 1.821. The company is able to pay all its short-term debts. +1
  • The TTM is 1.821. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.821TTM1.8210.000
TTM1.821YOY1.530+0.291
TTM1.8215Y1.415+0.406
5Y1.41510Y1.424-0.008
1.3.2. Quick Ratio

Measures if INDOCO REMEDIES LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare INDOCO REMEDIES LTD. to the  industry mean.
  • A Quick Ratio of 0.80 means the company can pay off ₹0.80 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of INDOCO REMEDIES LTD.:

  • The MRQ is 0.796. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.796. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.796TTM0.7960.000
TTM0.796YOY0.596+0.200
TTM0.7965Y0.588+0.208
5Y0.58810Y0.624-0.036

1.4. Solvency of INDOCO REMEDIES LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of INDOCO REMEDIES LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare INDOCO REMEDIES LTD. to industry mean.
  • A Debt to Asset Ratio of 0.39 means that INDOCO REMEDIES LTD. assets are financed with 39.1% credit (debt) and the remaining percentage (100% - 39.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of INDOCO REMEDIES LTD.:

  • The MRQ is 0.391. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.391. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.391TTM0.3910.000
TTM0.391YOY0.415-0.024
TTM0.3915Y0.440-0.049
5Y0.44010Y0.443-0.003
1.4.2. Debt to Equity Ratio

Measures if INDOCO REMEDIES LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare INDOCO REMEDIES LTD. to the  industry mean.
  • A Debt to Equity ratio of 64.3% means that company has ₹0.64 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of INDOCO REMEDIES LTD.:

  • The MRQ is 0.643. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.643. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.643TTM0.6430.000
TTM0.643YOY0.710-0.067
TTM0.6435Y0.792-0.150
5Y0.79210Y0.800-0.007

2. Market Valuation of INDOCO REMEDIES LTD.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings INDOCO REMEDIES LTD. generates.

  • Above 15 is considered overpriced but always compare INDOCO REMEDIES LTD. to the  industry mean.
  • A PE ratio of 27.01 means the investor is paying ₹27.01 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of INDOCO REMEDIES LTD.:

  • The EOD is 20.148. Very good. +2
  • The MRQ is 27.011. Very good. +2
  • The TTM is 27.011. Very good. +2
Trends
Current periodCompared to+/- 
EOD20.148MRQ27.011-6.864
MRQ27.011TTM27.0110.000
TTM27.011YOY30.132-3.121
TTM27.0115Y-99.534+126.545
5Y-99.53410Y-77.772-21.762
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of INDOCO REMEDIES LTD..

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of INDOCO REMEDIES LTD.:

  • The MRQ is 16.236. Seems overpriced? -1
  • The TTM is 16.236. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ16.236TTM16.2360.000
TTM16.236YOY7.810+8.425
TTM16.2365Y1,987.526-1,971.290
5Y1,987.52610Y1,987.5260.000

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of INDOCO REMEDIES LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 4.62 means the investor is paying ₹4.62 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of INDOCO REMEDIES LTD.:

  • The EOD is 3.448. Neutral. Compare to industry.
  • The MRQ is 4.622. Neutral. Compare to industry.
  • The TTM is 4.622. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD3.448MRQ4.622-1.174
MRQ4.622TTM4.6220.000
TTM4.622YOY3.646+0.976
TTM4.6225Y3.544+1.078
5Y3.54410Y3.566-0.021
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of INDOCO REMEDIES LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--14.72014.7200%9.704+52%5.498+168%16.362-10%
Book Value Growth--1.1761.1760%1.132+4%1.070+10%1.070+10%
Book Value Per Share--98.17098.1700%83.450+18%80.061+23%78.497+25%
Book Value Per Share Growth--1.1761.1760%1.132+4%1.070+10%1.070+10%
Current Ratio--1.8211.8210%1.530+19%1.415+29%1.424+28%
Debt To Asset Ratio--0.3910.3910%0.415-6%0.440-11%0.443-12%
Debt To Equity Ratio--0.6430.6430%0.710-9%0.792-19%0.800-20%
Dividend Per Share--1.4971.4970%0.303+395%1.058+41%0.926+62%
Dividend Per Share Growth--4.9464.9460%0.829+497%2.807+76%2.807+76%
Eps--16.79916.7990%10.097+66%6.733+150%7.005+140%
Eps Growth--1.6641.6640%3.858-57%3.258-49%3.258-49%
Free Cash Flow Per Share--5.2645.2640%0.583+803%2.967+77%0.647+714%
Free Cash Flow Per Share Growth--9.0279.0270%0.083+10717%3.376+167%3.376+167%
Free Cash Flow To Equity Per Share--0.4490.4490%-2.659+693%-1.224+373%-0.466+204%
Free Cash Flow To Equity Per Share Growth--2.1692.1690%-56.465+2704%-10.748+596%-10.748+596%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--145.254--------
Intrinsic Value_10Y_min--121.466--------
Intrinsic Value_1Y_max--7.283--------
Intrinsic Value_1Y_min--7.077--------
Intrinsic Value_3Y_max--27.426--------
Intrinsic Value_3Y_min--25.803--------
Intrinsic Value_5Y_max--54.250--------
Intrinsic Value_5Y_min--49.358--------
Net Profit Margin--0.1000.1000%0.075+34%0.047+115%0.051+98%
Operating Margin----0%-0%0.024-100%0.035-100%
Operating Ratio--1.1731.1730%1.183-1%1.072+9%0.957+23%
Pb Ratio3.448-34%4.6224.6220%3.646+27%3.544+30%3.566+30%
Pe Ratio20.148-34%27.01127.0110%30.132-10%-99.534+468%-77.772+388%
Peg Ratio--16.23616.2360%7.810+108%1987.526-99%1987.526-99%
Price Per Share338.450-34%453.750453.7500%304.250+49%289.400+57%284.425+60%
Price To Total Gains Ratio20.870-34%27.97927.9790%30.405-8%-82.893+396%-68.468+345%
Profit Growth--1.6641.6640%3.858-57%3.258-49%3.258-49%
Quick Ratio--0.7960.7960%0.596+34%0.588+35%0.624+28%
Return On Assets--0.1040.1040%0.071+47%0.045+132%0.048+116%
Return On Equity--0.1710.1710%0.121+41%0.077+123%0.084+104%
Revenue Growth--1.2411.2410%1.122+11%1.077+15%1.077+15%
Total Gains Per Share--16.21716.2170%10.006+62%6.556+147%17.287-6%
Total Gains Per Share Growth--1.6211.6210%4.133-61%2.914-44%2.914-44%
Usd Book Value--111270732.300111270732.3000%94585843.800+18%90744568.560+23%88972870.000+25%
Usd Book Value Change Per Share--0.1810.1810%0.119+52%0.068+168%0.201-10%
Usd Book Value Per Share--1.2071.2070%1.026+18%0.985+23%0.966+25%
Usd Dividend Per Share--0.0180.0180%0.004+395%0.013+41%0.011+62%
Usd Eps--0.2070.2070%0.124+66%0.083+150%0.086+140%
Usd Free Cash Flow--5966139.6005966139.6000%660891.300+803%3774299.280+58%3145249.400+90%
Usd Free Cash Flow Per Share--0.0650.0650%0.007+803%0.036+77%0.008+714%
Usd Free Cash Flow To Equity Per Share--0.0060.0060%-0.033+693%-0.015+373%-0.006+204%
Usd Price Per Share4.163-34%5.5815.5810%3.742+49%3.560+57%3.498+60%
Usd Profit--19040338.50019040338.5000%11444596.500+66%7631397.240+150%7939248.200+140%
Usd Revenue--189512680.500189512680.5000%152707907.100+24%145204174.020+31%143487277.700+32%
Usd Total Gains Per Share--0.1990.1990%0.123+62%0.081+147%0.213-6%
 EOD+3 -2MRQTTM+0 -0YOY+34 -75Y+34 -810Y+30 -12

3.2. Fundamental Score

Let's check the fundamental score of INDOCO REMEDIES LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1520.148
Price to Book Ratio (EOD)Between0-13.448
Net Profit Margin (MRQ)Greater than00.100
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.796
Current Ratio (MRQ)Greater than11.821
Debt to Asset Ratio (MRQ)Less than10.391
Debt to Equity Ratio (MRQ)Less than10.643
Return on Equity (MRQ)Greater than0.150.171
Return on Assets (MRQ)Greater than0.050.104
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of INDOCO REMEDIES LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose348.500
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets14,860,921
Total Liabilities5,814,520
Total Stockholder Equity9,046,401
 As reported
Total Liabilities 5,814,520
Total Stockholder Equity+ 9,046,401
Total Assets = 14,860,921

Assets

Total Assets14,860,921
Total Current Assets7,736,191
Long-term Assets7,736,191
Total Current Assets
Cash And Cash Equivalents 167,728
Short-term Investments 241,503
Net Receivables 2,972,446
Inventory 3,222,816
Other Current Assets 1,021,891
Total Current Assets  (as reported)7,736,191
Total Current Assets  (calculated)7,626,384
+/- 109,807
Long-term Assets
Property Plant Equipment 5,846,626
Goodwill 900
Intangible Assets 918,781
Long-term Assets Other 325,700
Long-term Assets  (as reported)7,124,730
Long-term Assets  (calculated)7,092,007
+/- 32,723

Liabilities & Shareholders' Equity

Total Current Liabilities4,248,536
Long-term Liabilities1,565,984
Total Stockholder Equity9,046,401
Total Current Liabilities
Short-term Debt 1,037,330
Short Long Term Debt 1,483,212
Accounts payable 1,332,906
Other Current Liabilities 856,851
Total Current Liabilities  (as reported)4,248,536
Total Current Liabilities  (calculated)4,710,299
+/- 461,763
Long-term Liabilities
Long term Debt Total 1,068,472
Capital Lease Obligations 124,612
Long-term Liabilities Other 74,053
Long-term Liabilities  (as reported)1,565,984
Long-term Liabilities  (calculated)1,267,137
+/- 298,847
Total Stockholder Equity
Common Stock184,301
Retained Earnings 8,220,007
Capital Surplus 642,093
Total Stockholder Equity (as reported)9,046,401
Total Stockholder Equity (calculated)9,046,401
+/-0
Other
Capital Stock184,301
Cash and Short Term Investments 167,728
Common Stock Shares Outstanding 92,150
Liabilities and Stockholders Equity 14,860,921
Net Debt 2,267,399
Net Invested Capital 11,488,462
Net Working Capital 3,487,655



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
11,967,479
12,379,289
12,580,498
12,715,951
13,150,615
14,860,921
14,860,92113,150,61512,715,95112,580,49812,379,28911,967,479
   > Total Current Assets 
5,720,503
5,389,612
5,380,522
5,631,038
6,225,262
7,736,191
7,736,1916,225,2625,631,0385,380,5225,389,6125,720,503
       Cash And Cash Equivalents 
229,428
73,243
202,730
237,621
87,868
167,728
167,72887,868237,621202,73073,243229,428
       Short-term Investments 
378,397
12,572
83,784
6,470
10
241,503
241,503106,47083,78412,572378,397
       Net Receivables 
2,162,611
2,101,240
1,964,823
2,112,801
2,338,238
2,972,446
2,972,4462,338,2382,112,8011,964,8232,101,2402,162,611
       Inventory 
1,869,450
1,933,827
1,834,506
2,083,166
2,585,014
3,222,816
3,222,8162,585,0142,083,1661,834,5061,933,8271,869,450
       Other Current Assets 
1,039,408
1,223,177
1,319,730
1,143,784
1,085,207
1,021,891
1,021,8911,085,2071,143,7841,319,7301,223,1771,039,408
   > Long-term Assets 
0
0
7,199,976
7,084,913
6,925,353
7,124,730
7,124,7306,925,3537,084,9137,199,97600
       Property Plant Equipment 
4,331,315
5,168,866
5,578,466
5,489,455
5,535,308
5,846,626
5,846,6265,535,3085,489,4555,578,4665,168,8664,331,315
       Goodwill 
900
900
900
900
900
900
900900900900900900
       Intangible Assets 
973,015
1,074,420
951,425
914,093
845,121
918,781
918,781845,121914,093951,4251,074,420973,015
       Long-term Assets Other 
0
0
0
-15
211,800
325,700
325,700211,800-15000
> Total Liabilities 
5,454,115
5,629,478
5,974,274
5,920,257
5,460,709
5,814,520
5,814,5205,460,7095,920,2575,974,2745,629,4785,454,115
   > Total Current Liabilities 
3,903,870
4,173,612
4,455,012
4,589,864
4,069,199
4,248,536
4,248,5364,069,1994,589,8644,455,0124,173,6123,903,870
       Short-term Debt 
1,183,580
1,099,314
1,133,937
1,059,786
1,163,238
1,037,330
1,037,3301,163,2381,059,7861,133,9371,099,3141,183,580
       Short Long Term Debt 
0
0
1,688,376
1,658,752
1,622,502
1,483,212
1,483,2121,622,5021,658,7521,688,37600
       Accounts payable 
1,640,293
1,495,497
1,707,227
1,656,037
1,132,258
1,332,906
1,332,9061,132,2581,656,0371,707,2271,495,4971,640,293
       Other Current Liabilities 
579,347
753,452
798,386
986,431
761,160
856,851
856,851761,160986,431798,386753,452579,347
   > Long-term Liabilities 
0
0
1,519,262
1,330,393
1,391,510
1,565,984
1,565,9841,391,5101,330,3931,519,26200
       Long term Debt Total 
1,323,097
1,232,759
1,286,571
1,024,211
1,039,444
1,068,472
1,068,4721,039,4441,024,2111,286,5711,232,7591,323,097
       Long-term Liabilities Other 
0
0
-1
1
0
74,053
74,05301-100
> Total Stockholder Equity
6,513,364
6,749,811
6,606,224
6,795,694
7,689,906
9,046,401
9,046,4017,689,9066,795,6946,606,2246,749,8116,513,364
   Common Stock
184,301
184,301
184,301
184,301
184,301
184,301
184,301184,301184,301184,301184,301184,301
   Retained Earnings 
5,687,008
5,923,449
5,779,828
5,969,298
6,863,512
8,220,007
8,220,0076,863,5125,969,2985,779,8285,923,4495,687,008
   Capital Surplus 
642,093
642,093
642,093
642,093
642,093
642,093
642,093642,093642,093642,093642,093642,093
   Treasury Stock000000
   Other Stockholders Equity 
-38
-32
2
2
0
0
0022-32-38



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue15,407,535
Cost of Revenue-5,223,793
Gross Profit10,183,74210,183,742
 
Operating Income (+$)
Gross Profit10,183,742
Operating Expense-12,848,753
Operating Income2,489,161-2,665,011
 
Operating Expense (+$)
Research Development746,419
Selling General Administrative5,823,573
Selling And Marketing Expenses-
Operating Expense12,848,7536,569,992
 
Net Interest Income (+$)
Interest Income126,916
Interest Expense-164,579
Net Interest Income-169,576-37,663
 
Pretax Income (+$)
Operating Income2,489,161
Net Interest Income-169,576
Other Non-Operating Income Expenses-
Income Before Tax (EBT)2,365,7122,489,161
EBIT - interestExpense = -164,579
1,547,995
1,712,574
Interest Expense164,579
Earnings Before Interest and Taxes (ebit)-2,530,291
Earnings Before Interest and Taxes (ebitda)3,302,380
 
After tax Income (+$)
Income Before Tax2,365,712
Tax Provision-817,717
Net Income From Continuing Ops1,547,9951,547,995
Net Income1,547,995
Net Income Applicable To Common Shares1,547,995
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-169,576
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
NGU24-NYM.COMM
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGU24-NYM.COMM.

NGU24-NYM.COMM Daily Candlestick Chart
NGM24-NYM.COMM
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGM24-NYM.COMM.

NGM24-NYM.COMM Daily Candlestick Chart
NGQ24-NYM.COMM
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGQ24-NYM.COMM.

NGQ24-NYM.COMM Daily Candlestick Chart
ISKJ.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ISKJ.MCX.

ISKJ.MCX Daily Candlestick Chart
CHKZ.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CHKZ.MCX.

CHKZ.MCX Daily Candlestick Chart
VSYD.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VSYD.MCX.

VSYD.MCX Daily Candlestick Chart
VRSB.MCX
5 hours ago

I found you a Golden Cross on the daily chart of VRSB.MCX.

VRSB.MCX Daily Candlestick Chart
TBRU.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBRU.MCX.

TBRU.MCX Daily Candlestick Chart
SNGSP.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SNGSP.MCX.

SNGSP.MCX Daily Candlestick Chart
RBCM.MCX
5 hours ago

I found you a Golden Cross on the daily chart of RBCM.MCX.

RBCM.MCX Daily Candlestick Chart
OKEY.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of OKEY.MCX.

OKEY.MCX Daily Candlestick Chart
MTLR.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MTLR.MCX.

MTLR.MCX Daily Candlestick Chart
MRKZ.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MRKZ.MCX.

MRKZ.MCX Daily Candlestick Chart
KRKN.MCX
5 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of KRKN.MCX.

KRKN.MCX Daily Candlestick Chart
JNOS.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JNOS.MCX.

JNOS.MCX Daily Candlestick Chart
BLNG.MCX
5 hours ago

I found you a Golden Cross on the daily chart of BLNG.MCX.

BLNG.MCX Daily Candlestick Chart
ASSB.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ASSB.MCX.

ASSB.MCX Daily Candlestick Chart
CSYZ.MU
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CSYZ.MU.

CSYZ.MU Daily Candlestick Chart
MOH.MU
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MOH.MU.

MOH.MU Daily Candlestick Chart
TBK.V
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBK.V.

TBK.V Daily Candlestick Chart
UMDK.F
5 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of UMDK.F.

UMDK.F Daily Candlestick Chart
RY4C.BE
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RY4C.BE.

RY4C.BE Daily Candlestick Chart
PLY.BE
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PLY.BE.

PLY.BE Daily Candlestick Chart
PDL.LSE
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PDL.LSE.

PDL.LSE Daily Candlestick Chart
27F0.MU
5 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of 27F0.MU.

27F0.MU Daily Candlestick Chart